Sodium cantharidinate suppresses human osteosarcoma MG‑63 cell proliferation and induces cell cycle arrest by inhibition of PI3K/AKT activation

Kong,Da‑Liang; Liu,Yang; Wang,Jing‑Ying; Liu,Gong; Zhang,Ming‑Lei

doi:10.3892/or.2018.6906

Sodium cantharidinate suppresses human osteosarcoma MG‑63 cell proliferation and induces cell cycle arrest by inhibition of PI3K/AKT activation

Authors:
- Da‑Liang Kong
- Yang Liu
- Jing‑Ying Wang
- Gong Liu
- Ming‑Lei Zhang
View Affiliations

Affiliations: Department of Orthopaedics, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Radiological Department, The Second Hospital of Jilin University, Changchun, Jilin 130022, P.R. China, Clinical Laboratory, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Orthopaedics, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: December 6, 2018 https://doi.org/10.3892/or.2018.6906
Pages: 1351-1358

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The function and mechanism of sodium cantharidininate (SC) underlying its suppression of human osteosarcoma (OS) MG‑63 cells were investigated for the first time in the present study. MG‑63 cell proliferation was determined by WST‑1 assay post SC treatment at 0, 12, 24, 48 and 72 h. The results showed that SC effectively inhibited MG‑63 cell proliferation and induced cell cycle arrest at the G0/G1 phase in a dose‑dependent manner. Western blotting revealed that SC induced MG‑63 cell cycle arrest at the G0/G1 phase by means of inhibition of cyclin D1, CDK4 and CDK6 expression. The expression of MAPK and AKT were evaluated using western blotting and FACS experiments to determine whether such signaling pathways are involved in the antiproliferative action of SC on MG‑63 cells. SC significantly inhibited the phosphorylation of AKT, but not mTOR, JNK or P38. PI3K/AKT stimulator, IGF‑1, reversed the SC‑induced cell cycle arrest in the MG‑63 cells. Collectively, our data indicate that the phosphorylation of AKT was inhibited by SC, consequently decreasing the expression of cyclin D1, CDK4 and CDK6 and inducing MG‑63 cell G0/G1 phase arrest. SC has potential as a treatment agent for human osteosarcoma.

View Figures

View References

1	Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
2	Torres K and Horwitz SB: Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res. 58:3620–3626. 1998.PubMed/NCBI
3	Anderson ME: Update on survival in osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
4	Ferrari S and Serra M: An update on chemotherapy for osteosarcoma. Expert Opin Pharmacother. 16:2727–2736. 2015. View Article : Google Scholar : PubMed/NCBI
5	Jaffe N: Osteosarcoma. Review of the past, impact on the future. The American experience. Cancer Treat Res. 152:239–262. 2009. View Article : Google Scholar : PubMed/NCBI
6	Ferguson JL and Turner SP: Bone cancer: Diagnosis and treatment principles. Am Fam Physician. 98:205–213. 2018.PubMed/NCBI
7	Liu Q, Xu B and Zhou W: Correlation between chemotherapy resistance in osteosarcoma patients and PAK5 and Ezrin gene expression. Oncol Lett. 15:879–884. 2018.PubMed/NCBI
8	Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA and Anders RA: Expression of Yes-associated protein in common solid tumors. Hum Pathol. 39:1582–1589. 2008. View Article : Google Scholar : PubMed/NCBI
9	Yin J, Dong Q, Zheng M, Xu X, Zou G, Ma G and Li K: Antitumor activity of dobutamine on human osteosarcoma cells. Oncol Lett. 11:3676–3680. 2016. View Article : Google Scholar : PubMed/NCBI
10	Shah U, Shah R, Acharya S and Acharya N: Novel anticancer agents from plant sources. Chin J Nat Med. 11:16–23. 2013. View Article : Google Scholar
11	Khan F, Ahmed F, Pushparaj PN, Abuzenadah A, Kumosani T, Barbour E, AlQahtani M and Gauthaman K: Ajwa date (Phoenix dactylifera L.) extract inhibits human breast adenocarcinoma (MCF7) cells in vitro by inducing apoptosis and cell cycle arrest. PLoS One. 11:e01589632016. View Article : Google Scholar : PubMed/NCBI
12	Gerber DE: Targeted therapies: A new generation of cancer treatments. Am Fam Physician. 77:311–319. 2008.PubMed/NCBI
13	Tsauer W, Lin JG, Lin PY, Hsu FL and Chiang HC: The effects of cantharidin analogues on xanthine oxides. Anticancer Res. 17:2095–2098. 1997.PubMed/NCBI
14	Lin LH, Huang HS, Lin CC, Lee LW and Lin PY: Effects of cantharidinimides on human carcinoma cells. Chem Pharm Bull. 52:855–857. 2004. View Article : Google Scholar : PubMed/NCBI
15	Yeh CB, Su CJ, Hwang JM and Chou MC: Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells. Eur J Med Chem. 45:3981–3985. 2010. View Article : Google Scholar : PubMed/NCBI
16	Tao R, Sun WY, Yu DH, Qiu W, Yan WQ, Ding YH, Wang GY and Li HJ: Sodium cantharidinate induces HepG2 cell apoptosis through LC3 autophagy pathway. Oncol Rep. 38:1233–1239. 2017. View Article : Google Scholar : PubMed/NCBI
17	Zhang I, Beus M, Stochaj U, Le PU, Zorc B, Rajić Z, Petrecca K and Maysinger D: Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule. Cell Death Discov. 5:412018. View Article : Google Scholar
18	Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J and Tercé F: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60:1426–1433. 2000.PubMed/NCBI
19	Stewart ZA, Westfall MD and Pietenpol JA: Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
20	Hindley C and Philpott A: Co-ordination of cell cycle and differentiation in the developing nervous system. Biochem J. 444:375–382. 2012. View Article : Google Scholar : PubMed/NCBI
21	Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
22	Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
23	Robertson JD and Orrenius S: Role of mitochondria in toxic cell death. Toxicology. 181–182. 491–496. 2002.PubMed/NCBI
24	Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
25	Basu-Roy U, Basilico C and Mansukhani A: Perspectives on cancer stem cells in osteosarcoma. Cancer Lett. 338:158–167. 2013. View Article : Google Scholar : PubMed/NCBI
26	Shangguan WJ, Li H and Zhang YH: Induction of G2/M phase cell cycle arrest and apoptosis by ginsenoside Rf in human osteosarcoma MG-63 cells through the mitochondrial pathway. Oncol Rep. 31:305–313. 2014. View Article : Google Scholar : PubMed/NCBI
27	Liu L, Xu Y, Reiter RJ, Pan Y, Chen D, Liu Y, Pu X, Jiang L and Li Z: Inhibition of ERK1/2 signaling pathway is involved in melatonin's antiproliferative effect on human MG-63 osteosarcoma cells. Cell Physiol Biochem. 39:2297–2307. 2016. View Article : Google Scholar : PubMed/NCBI
28	Huang HW, Tang JY, Ou-Yang F, Wang HR, Guan PY, Huang CY, Chen CY, Hou MF, Sheu JH and Chang HW: Sinularin selectively kills breast cancer cells showing G2/M arrest, apoptosis, and oxidative DNA damage. Molecules. 23:E8492018. View Article : Google Scholar : PubMed/NCBI
29	Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J and Yan H: Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways. J Exp Clin Cancer Res. 37:632018. View Article : Google Scholar : PubMed/NCBI
30	Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, et al: Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. Br J Cancer. 114:945–952. 2016. View Article : Google Scholar : PubMed/NCBI